Ignite Creation Date:
2025-12-24 @ 4:09 PM
Ignite Modification Date:
2025-12-28 @ 5:44 PM
Study NCT ID:
NCT00146666
Status:
UNKNOWN
Last Update Posted:
2009-12-17
First Post:
2005-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)
Sponsor:
FlowMedic
Organization:
Study Overview
Official Title:
Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)
Status:
UNKNOWN
Status Verified Date:
2009-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether 12 weeks of daily home use of the FM220 in the most affected leg of patients with PAD and claudication, will improve peak walking time (PWT) at three months as compared with a non-treated control group.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: